TJCC - Movimento Todos Juntos Contra o Câncer

What TJCC - Movimento Todos Juntos Contra o Câncer does

TJCC (Movimento Todos Juntos Contra o Câncer) is a Brazilian civil society oncology coalition founded in 2014 by ABRALE (Associação Brasileira de Câncer do Sangue), led by Merula Steagall, and headquartered in São Paulo. It functions as a multi-stakeholder advocacy movement rather than a commercial enterprise, self-described as the largest oncology coalition in Brazil, with over 300 individual members and more than 200 member organizations spanning patient associations, hospitals, medical societies, research institutions, pharmaceutical companies, government agencies, and academic institutions across all Brazilian states. Its core activities center on influencing national cancer care policy through 18 thematic Working Groups (GTs), direct engagement with the Ministry of Health, CONITEC, ANVISA, ANS, INCA, and CNJ, and facilitation of public consultations.

The coalition operates two principal digital platforms: Onco Ensino, an educational platform supporting oncology training in healthcare units performing cancer diagnosis and treatment, and Observatório de Oncologia, an open-data monitoring platform launched in 2015 that consolidates oncology indicators and tracks implementation of the National Cancer Prevention and Control Policy (PNPCC). Distribution and stakeholder engagement are event-driven: the annual Congresso TJCC (13th edition scheduled for September 2026 at WTC Events Center), regional Fóruns TJCC (notably in the North and Northeast), the Diálogos em Oncologia webinar series, the TJCC no Ar podcast, and the De Olho na Política citizen-monitoring panel. The Declaração para Melhoria da Atenção ao Câncer no Brasil, first produced in 2014 and updated biennially, serves as the coalition's guiding policy framework.

TJCC is a non-profit civil society movement that does not sell commercial products or services and generates no disclosed revenue. Participation in events, working groups, and platforms is free; financial support flows through ABRALE, participating member organizations, event sponsors, and institutional backers. The core operating team is very small (7 employees), while the coalition's reach is amplified by its distributed network of member organizations, volunteer specialists, and government partners.

Name

TJCC - Movimento Todos Juntos Contra o Câncer

Legal name

Movimento Todos Juntos Contra o Câncer

Website

https://tjcc.com.br

Company type

Private

Founded year

2014

Operating status

Operating

Short description

Movimento Todos Juntos Contra o Câncer (TJCC) is Brazil's largest oncology advocacy coalition, founded in 2014 by ABRALE, unifying 300+ members and 200+ organizations to influence cancer policy through education, data monitoring, and stakeholder engagement.

Ownership category

akta.pro rank

Product category

Healthcare Advocacy and Policy Coalition

NAICS

Social Advocacy Organizations (8133), Business Associations (813910)

SIC

Services-Membership Organizations (8600), Services-Social Services (8300)

akta.pro primary industry

Global Health Advocacy, Policy & Rights Organizations (HLAJAKAO)

akta.pro secondary industries

Public Health Communications, Risk Communication & Community Engagement (HLAJAMAH), Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Oncology advocacy coalition
• Cancer policy monitoring
• Oncology education platform
• Health policy influence
• Civil society movement

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership and organizational support: The movement is funded through its member organizations, with ABRALE serving as the leading organization. Financial support comes from participating organizations, event sponsors, and institutional backers. No commercial product revenue is generated.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

TJCC is a civil society coalition that drives cancer policy advocacy in Brazil by uniting patient associations, hospitals, medical societies, research institutions, pharmaceutical companies, and government bodies. Its core offerings include the Observat\u00f3rio de Oncologia open-data monitoring platform, the Onco Ensino distance-learning platform, the annual Congresso TJCC, regional F\u00f3runs, the Di\u00e1logos em Oncologia dialogue series, the TJCC no Ar podcast, the De Olho na Pol\u00edtica citizen-monitoring panel, and 18 thematic working groups that engage in policy advocacy with regulators and legislators.

Product overview

TJCC (Movimento Todos Juntos Contra o Câncer) is a coalition led by ABRALE that operates as a cancer advocacy and policy influence organization rather than a traditional technology company. Its main platforms include Onco Ensino (an educational platform for oncology professionals) and the Observatório de Oncologia (a data monitoring platform), alongside events such as the annual Congresso TJCC, regional Fóruns, and the Diálogos em Oncologia discussion series. The movement also produces the Declaração policy framework and maintains the 'De Olho na Política' monitoring platform for citizen-reported cancer policy implementation feedback. These offerings function together as an advocacy ecosystem focused on improving cancer care policy and access in Brazil.

Differentiator

Problem solved

Functional benefit

Brands

• Observatório de Oncologia: Online platform for consolidation, analysis, and publication of open data and sharing of relevant information in the Oncology area of Brazil, launched in 2015.
• Onco Ensino
• Congresso TJCC
• Fóruns Regionais TJCC
• Diálogos em Oncologia
• TJCC no Ar
• De Olho na Política

Products and services

• Onco Ensino Educational platform developed by ABRALE to support healthcare units that perform cancer diagnosis and treatment in Brazil, providing distance-learning resources for oncology professionals.
• Observat\u00f3rio de Oncologia Online open-data platform for consolidation, analysis, and publication of oncology data in Brazil, monitoring implementation of the National Cancer Prevention and Control Policy (PNPCC) and supporting evidence-based policy.
• Congresso TJCC Annual congress bringing together thousands of oncology leaders, with debate panels and speakers across multiple simultaneous rooms to discuss oncology care improvement in Brazil.
• F\u00f3runs Regionais TJCC Regional forums held across Brazil gathering doctors, health professionals, government representatives, hospitals, and patient support organizations to debate oncology treatment needs and solutions.
• Di\u00e1logos em Oncologia Discussion series that deepens complex themes about oncology care through dialogue with specialists, including innovative treatment access, SUS dynamics, personalized medicine, and financial sustainability.
• TJCC no Ar (Podcast) Podcast series of the TJCC movement covering topics such as clinical research, public policies, and oncology care in Brazil, distributed via YouTube and Spotify.
• Declara\u00e7\u00e3o para Melhoria da Aten\u00e7\u00e3o ao C\u00e2ncer no Brasil Policy framework document serving as the guiding framework for the TJCC movement's work, updated every two years and aligned with the National Cancer Prevention and Control Policy.
• De Olho na Pol\u00edtica - Painel Nacional de Monitoramento National monitoring panel where citizens can share experiences about how cancer policy is implemented in their regions, contributing to PNPCC implementation monitoring.
• Grupos de Trabalho (GTs) Eighteen thematic working groups composed of specialists from various oncology-related areas who voluntarily participate in periodic meetings to collaboratively develop advocacy projects and public policies.

Quantifiable outcome

• 8th Congress TJCC (2021, online) recorded more than 30,000 accesses with debates on promotion, prevention, diagnosis, treatment, management, palliative care, and COVID-19 impacts.
• +3 more outcomes

Named customers88 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• ABRALE (Associação Brasileira de Câncer do Sangue)coreStrategic or Co-development PartnerABRALE is the leading and founding organization of the TJCC movement. Founded by Merula Steagall, ABRALE initiated the coalition in 2014 and continues to host the movement's platforms (Onco Ensino, Observatório de Oncologia) and coordinate its activities. The movement was created under ABRALE's leadership and is governed by its strategic council.
• Merula SteagallcoreOthersFounder of ABRALE and originator of the TJCC movement concept. Proposed the initial collaboration that led to the 1st Congress in 2014 and the creation of the Declaração para Melhoria da Atenção ao Câncer no Brasil.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ABRALE (Associação Brasileira de Câncer do Sangue): ABRALE is the founding and leading organization of TJCC, a Brazilian blood-cancer patient association that also hosts the movement's platforms (Onco Ensino, Observatório de Oncologia). Directly comparable as the parent civil-society organization and a Brazilian oncology advocacy peer.
• FEMAMA (Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama): Brazilian federation of breast cancer patient support organizations and a member of TJCC. Comparable as a Brazilian oncology-specific civil-society coalition engaged in policy advocacy and patient support.
• Instituto Oncoguia: Brazilian cancer patient advocacy organization that is a member of TJCC. Comparable as a non-profit focused on patient rights, treatment access, and oncology information in Brazil.
• ACBG (Associação Brasileira de Câncer Ginecológico): Brazilian gynecological cancer association and TJCC member organization. Comparable as a disease-specific oncology advocacy organization operating within the Brazilian civil-society ecosystem.

Broad incumbents

• SBOC (Sociedade Brasileira de Oncologia Clínica): Brazilian Society of Clinical Oncology, a medical specialty society and TJCC member. Comparable as a larger, established player in the Brazilian oncology ecosystem that participates in TJCC's working groups.
• INCA (Instituto Nacional de Câncer): Brazil's federal government cancer institute and a member of TJCC. Comparable as the principal public-sector oncology authority whose policy outputs TJCC actively engages with and monitors.
• Interfarma (Associação da Indústria Farmacêutica de Pesquisa): Brazilian pharmaceutical research-industry association and TJCC member. Comparable as a broader-incumbent industry association that participates in TJCC's oncology policy working groups.
• Union for International Cancer Control (UICC): Global cancer-control membership organization headquartered in Geneva. Comparable as a larger, established global oncology advocacy coalition with a multi-stakeholder model analogous to TJCC's Brazilian coalition.
• American Cancer Society: Large U.S.-based non-profit cancer advocacy, research, and patient-support organization. Comparable as a broad-incumbent global cancer advocacy organization with similar civil-society coalition, policy-influence, and patient-navigation functions.

Others

• CONITEC (Comissão Nacional de Incorporação de Tecnologias no SUS): Brazilian national commission for health technology incorporation in the public health system (SUS). TJCC mobilizes members to participate in CONITEC's public consultations on oncology technologies; comparable as a regulatory counterpart rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/movimentotjcc
• YouTubeyoutube.com/channel/UCruNrncMrCgvBkGPxOCgxkg
• Facebookfacebook.com/todosjuntoscontraocancer
• Instagraminstagram.com/movimentotjcc

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TJCC - Movimento Todos Juntos Contra o Câncer